20 - Antihyperlipidemics Flashcards

(48 cards)

1
Q

most dense =

A

HDL

the least dense would be a chylomicron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

dietary triglycerides and cholesteryl esters

A

chylomicron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

endogenous triglycerides and cholesteryl esters

A

VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cholesteryl esters and endogenous triglycerides

A

IDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

apoprtns associated with chylomicron

A

B-48
C
E
A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

apoprtns associated with VLDL

A

C
B-100
E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

apoprtns associated with LDL

A

B-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

apoprtns associated with HDL

A
A-I
A-II
C
E
D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 roles of lipoprtns

A
  1. serve as cofactors for enzymes involved in lipoprtn metabolism
  2. serve as ligands for receptors
  3. structual stabillity of lipoprtns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chylomicron metabolism

A
  1. nascent TAG rich chylomicrons with apoB48 leave the small intestine
  2. Apo C and Apo E added to chylomicron from HDL
  3. lipoprtn lipase degrades TAG in CM at adipose tissue
  4. Apoc C is returned to HDL
  5. CE rick CM remnant bind through apoE to receptors on liver where endocytosed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what activates lipoprtn lipase?

A

apo C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

metabolism of hepatic origin lipoprtns

A
  1. liver secretes nascent TAG rich VLDLs with Apo B100
  2. Apo C and Apo E transferred to VLDL from HDL
  3. Liportn lipase activated by apoC degrades TAG in VLDL
  4. Apo C and Apo E returned to HDL (NOW AN IDL)
  5. LDL binds to specific receptors and are endocytosed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the only place where cholesterol can be eliminated

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

___ of bile acids/salts are excreted in feces daily

A

5%

95% reabsorbed and returned to liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

accepts excess cholesterol from peripheral tissues

A

HDL

HDL is transported to the liver where it binds to SRB1 through ApoA and CE are selectively delivered to hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what enzyme turns a nascent HDL into a CE full mature HDL

A

LCAT

lecithin:cholesterol acyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what apoprtn activates LCAT

A

apoA-I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which apoprtn is a cofactor for lipoprtn lipase

A

Apo C-II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Major goals of clinical management of dyslipidemia

A
  • prevent acute pancreatitis
    (severe hypertriglyceridemia)
  • preventionof cardiovascular disease (reduce LDL reduces CVD risk)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

cause primary chylomicronemia

A

decreased lipoprtn lipase activity

21
Q

manifestation primary chylomicronemia

A

increased chylomicrons/VLDL

22
Q

cause familial hypertriglyceridemia

A

impaired removal of VLDL and or chylomicrons

23
Q

manifestation of familial hypertriglyceridemia

A

increased VLDL and chylomicrons

24
Q

cause familial combined hyperliproteinemia

A

increased VLDL production and high conversion of VLDL to LDL

25
manifestation of familial hyperlipoproteinemia
increased VLDL and LDL
26
cause familial dysbetalipoproteinemia
decreased cleareance of VLDL IDL and chylomicron remnant because of a dysfunction or absence of apoE
27
manifestation of familial dybetalipoproteinemia
increased IDL and chylomicrons
28
cause familal hypercholesterolemia
LDLR impairments, high fat diet, inactivity
29
manifestation of familial hypercholesterolemia
increased LDL
30
cause familal ligand-defective apoB
mutation in apoB100 resulting in impaired endocytosis of LDL
31
manifestation of familal ligand-defective apoB
increased LDL
32
present in 20% of individuals who get coronary heart disease under 60
familial combined hyperlipidemia -- liver overproduces VLDL
33
MOA gemfibrozil and fenofibrate
PPAR actiavtor - decreases plasma triglycerides - increases plasma HDL (increased reverse cholesterol transport) - increased oxidation of fatty acids
34
MOA cholestyramine colestipol colaevelam
bidn to bile acids and bile salts in the intestine
35
effects of bile acid-binding resins
decreased LDL but increased TAG
36
drug of choice to lower cholesterol in children and women who are pregnant or lactating
bile acid sequestrants
37
side effects of bile acid binding resins
bloating and constipation
38
how does niacin reduce both triglycerides and cholesterol?
- reduces hormone sensitive lipase to reduce FFA in plasma --> decreased VLDL and LDL - also increases plasma HDL levels
39
which enzyme does niacin target to decrease FFA?
hormone sensitive lipase
40
side effect of niacin is reduced by what
flushing and itching can be reduced by pretreatment with NSAID
41
what statin is safest to combine with niacin?
fluvastatin highest risk is lovastatin
42
inhibitor of cholesterol absorption
ezetimibe blocks uptake of dietary cholesterol and reabsorption of cholesterol excreted in bile
43
what enyme does ezetimibe target?
niemann-pick C1 like prtn
44
most potent statins
atorvastatin and rosuvastatin least = fluvastatin
45
statins aka
HMG CoA reducatase inhibitors decreases CE in cell, causing uptake of LDL from the blood
46
indications for statins
elevated LDL CVD elevated CVD risk
47
which drug would be used for treatement of primary chylomicronemmia?
fibrates: gemfibrozil or fenofibrate would also be used for familial dysbetaliprotenemia
48
what drugs would be used to treat familial ligand-defective apoB
statins or ezetimibe